Brendan Chen

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 271 citations

Life Sciences, Infectious Diseases, Microbiology +16

Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection

Bryce K. Perler, Brendan Chen, Emmalee Phelps et al. · Journal of Clinical Gastroenterology · 2020 · 54 citations

Life Sciences, Infectious Diseases, Microbiology +13

Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy

Boudewijn L. M. de Jonge, Grant K. Walkup, Sushmita D. Lahiri et al. · Antimicrobial Agents and Chemotherapy · 2013 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Optimization of antibacterial activity

S. Stokes, Hoan K. Huynh, Madhusudhan Gowravaram et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 34 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +14

Transabdominal robotic repair of a congenital right diaphragmatic hernia containing an intrathoracic kidney: a case report

Brendan Chen, Neal J. Schamberg, Anthony C. Watkins et al. · Journal of Robotic Surgery · 2015 · 27 citations

Medicine, Surgery, Medical Robotics +11